\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes MSCA MSCAIn case you were not able to register for onsite attendance in Mons at the Marie Skłodowska-Curie Actions (MSCA) Presidency Conference 2024 on the multiple pathways of researchers' careers rest assured that you can participate anyway. Did you know that it is possible to watch the conference from anywhere in the world on your screen?
The whole conference except the parallel sessions on 18 April (workshop 1, 2 & 3 and roundtable 2) are web streamed live. Check out the biographies of all speakers at the conference and the 15 MSCA Falling Walls Lab contestants. The full agenda and web stream of the conference are available on the MSCA Presidency Conference website here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Horizon Europe Digital Europe
Building on the revised Charter for access to research infrastructures , this new Charter will be specifically aimed at facilitating access of companies. It will make it easier for companies, especially small and medium-sized businesses (SMEs), startups and scaleups, to access Europe’s world-class research and technology... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
